Andrew D. Patterson spends much of his time researching Internal medicine, Endocrinology, Farnesoid X receptor, Bile acid and Gut flora. His Internal medicine research incorporates elements of Gastroenterology and Pathology. The various areas that Andrew D. Patterson examines in his Endocrinology study include Nonalcoholic fatty liver disease and Inulin.
His Farnesoid X receptor research is multidisciplinary, relying on both G protein-coupled bile acid receptor, Lipid metabolism and Signal transduction. His work carried out in the field of Signal transduction brings together such families of science as Intestinal absorption, Nuclear receptor and Taurocholic acid. As part of his studies on Bile acid, Andrew D. Patterson often connects relevant subjects like Steatosis.
Andrew D. Patterson mainly focuses on Internal medicine, Endocrinology, Metabolomics, Biochemistry and Gut flora. His study brings together the fields of Methionine and Internal medicine. His studies in Endocrinology integrate themes in fields like Farnesoid X receptor and Signal transduction.
His Metabolomics study combines topics from a wide range of disciplines, such as Metabolite, Tandem mass spectrometry, Computational biology and Microbiome. Andrew D. Patterson has included themes like Pharmacology and Mass spectrometry in his Biochemistry study. His work investigates the relationship between Gut flora and topics such as Metabolism that intersect with problems in Cell biology.
His main research concerns Internal medicine, Gut flora, Endocrinology, Bile acid and Metabolomics. Internal medicine is closely attributed to Gut microbiome in his study. His Gut flora research includes themes of Hypoxia-inducible factors and Microbiology.
His Endocrinology study combines topics in areas such as Inflammation and Complement system. Bile acid is a primary field of his research addressed under Biochemistry. The study incorporates disciplines such as Microbiome, Lipid metabolism, Immunology and Drug in addition to Metabolomics.
His primary areas of study are Gut flora, Internal medicine, Endocrinology, Biochemistry and Bile acid. His Gut flora research focuses on subjects like Insulin resistance, which are linked to Lactobacillus johnsonii, Nutrient sensing, Glycodeoxycholic acid and Tauroursodeoxycholic acid. Internal medicine is often connected to Metabolomics in his work.
His study in the field of Lipopolysaccharide is also linked to topics like Persistent organic pollutant. His work focuses on many connections between Biochemistry and other disciplines, such as Bacteria, that overlap with his field of interest in Taurocholic acid, Berberine, Glucose homeostasis and Farnesoid X receptor. His work deals with themes such as Amino acid, Bifidobacterium, Microbial metabolism, Polycystic ovary and Transplantation, which intersect with Bile acid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray;Andrew D. Patterson;Gary H. Perdew.
Nature Reviews Cancer (2014)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li;Changtao Jiang;Kristopher W. Krausz;Yunfei Li.
Nature Communications (2013)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang;Changtao Jiang;Cen Xie;Fei Li;Limin Zhang.
Journal of Clinical Investigation (2015)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.
Lulu Sun;Cen Xie;Guang Wang;Yue Wu.
Nature Medicine (2018)
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota
Guolin Li;Guolin Li;Cen Xie;Siyu Lu;Robert G. Nichols.
Cell Metabolism (2017)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Changtao Jiang;Cen Xie;Ying Lv;Jing Li.
Nature Communications (2015)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak;Cen Xie;Robert G. Nichols;Jessica M. Ferrell.
Hepatology (2018)
Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.
Andrew D. Patterson;Olivier Maurhofer;Diren Beyoğlu;Christian Lanz.
Cancer Research (2011)
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.
Vishal Singh;Beng San Yeoh;Benoit Chassaing;Xia Xiao.
Cell (2018)
Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.
Limin Zhang;Robert G. Nichols;Jared Correll;Iain A. Murray.
Environmental Health Perspectives (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
University of Bern
Pennsylvania State University
Georgetown University
Pennsylvania State University
Pennsylvania State University
University of California, San Francisco
National Institutes of Health
Pennsylvania State University
Alfréd Rényi Institute of Mathematics
Gazi University
University of Tübingen
University of Michigan–Ann Arbor
University of Washington
University of Guelph
National Centre of Scientific Research Demokritos
Memorial Sloan Kettering Cancer Center
Stanford University
Barrow Neurological Institute
University of Giessen
University of Tromsø - The Arctic University of Norway
Ruhr University Bochum
Stanford University
University of Colorado Boulder
Brookhaven National Laboratory